The latest from TV, Radio, and Newspapers

Add a news source

Are we missing a Brisbane news source? Let us know!

Brisbane Newswire

Comprehensive Real-Time News Feed for Brisbane, CA.

Results 1 - 20 of 46 for "u:americanbankingnews.com" in Brisbane, CA

  1. Research Analysts' Updated EPS Estimates for December, 14th (ABGLF, ...Read the original story w/Photo

    Yesterday | AmericanBankingNews.com

    According to Zacks, "Acacia Mining plc is a mining company which acquires and explores primarily for gold. The Company's producing mines consists of Bulyanhulu, Buzwagi and North Mara and a portfolio of exploration projects in Tanzania, Kenya and Burkina Faso.

    Comment?

  2. Equities Research Analysts' Upgrades for November, 30th (ATRA,...Read the original story w/Photo

    Friday Nov 30 | AmericanBankingNews.com

    According to Zacks, "Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology.

    Comment?

  3. Financial Analysis: CelcuityRead the original story w/Photo

    Oct 27, 2018 | AmericanBankingNews.com

    Celcuity and CareDx are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, valuation, risk and analyst recommendations. 14.2% of Celcuity shares are held by institutional investors.

    Comment?

  4. Financial Contrast: CuteraRead the original story w/Photo

    Sep 18, 2018 | AmericanBankingNews.com

    Cutera and Reshape Lifesciences are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation. Cutera has a beta of 0.27, indicating that its stock price is 73% less volatile than the S&P 500.

    Comment?

  5. Analysts' Updated EPS Estimates for August, 27th (BYSI, CCCGY,...Read the original story w/Photo

    Aug 27, 2018 | AmericanBankingNews.com

    According to Zacks, "BeyondSpring Inc. is a clinical stage biopharmaceutical company. It focused on the development of cancer therapies.

    Comment?

  6. Head to Head Analysis: AkornRead the original story w/Photo

    Aug 26, 2018 | AmericanBankingNews.com

    Aimmune Therapeutics and Akorn are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, earnings, dividends and analyst recommendations. Aimmune Therapeutics has a beta of -0.24, suggesting that its stock price is 124% less volatile than the S&P 500.

    Comment?

  7. Head-To-Head Survey: Zealand Pharma/SRead the original story w/Photo

    Aug 18, 2018 | AmericanBankingNews.com

    ZEALAND PHARMA/S and Aimmune Therapeutics are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. 10.9% of ZEALAND PHARMA/S shares are owned by institutional investors.

    Comment?

  8. Critical Survey: Natus MedicalRead the original story w/Photo

    Aug 6, 2018 | AmericanBankingNews.com

    Cutera and Natus Medical are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, earnings, dividends, analyst recommendations, institutional ownership and valuation. Cutera has higher earnings, but lower revenue than Natus Medical.

    Comment?

  9. Analyzing CareDxRead the original story w/Photo

    Jul 28, 2018 | AmericanBankingNews.com

    CareDx and First Choice Healthcare Solutions are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings. This is a summary of current recommendations and price targets for CareDx and First Choice Healthcare Solutions, as provided by MarketBeat.com.

    Comment?

  10. Cutera (CUTR) vs. NxStage Medical (NXTM) Head to Head SurveyRead the original story w/Photo

    Jul 27, 2018 | AmericanBankingNews.com

    Cutera and NxStage Medical are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations. 96.6% of Cutera shares are held by institutional investors.

    Comment?

  11. Investment Analysts' Updated EPS Estimates for July, 24th (ADMP,...Read the original story w/Photo

    Jul 24, 2018 | AmericanBankingNews.com

    They currently have $4.50 price target on the stock. According to Zacks, "Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the treatment of viral infections.

    Comment?

  12. Head-To-Head Comparison: CuteraRead the original story w/Photo

    Jul 19, 2018 | AmericanBankingNews.com

    Cutera and AxoGen, Inc Common Stock are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability. Cutera has a beta of 0.44, meaning that its stock price is 56% less volatile than the S&P 500.

    Comment?

  13. Cutera (CUTR) versus Natus Medical (BABY) Financial ContrastRead the original story w/Photo

    Jul 15, 2018 | AmericanBankingNews.com

    Cutera and Natus Medical are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings. Cutera presently has a consensus target price of $54.00, suggesting a potential upside of 24.42%.

    Comment?

  14. Cutera (CUTR) versus Rockwell Medical (RMTI) Financial AnalysisRead the original story w/Photo

    Jul 14, 2018 | AmericanBankingNews.com

    Cutera and Rockwell Medical are both small-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations and institutional ownership. Cutera has higher revenue and earnings than Rockwell Medical.

    Comment?

  15. Research Analysts' Updated EPS Estimates for July, 11th (CDNA,...Read the original story w/Photo

    Jul 11, 2018 | AmericanBankingNews.com

    The firm currently has $14.00 target price on the stock. According to Zacks, "CareDx, Inc. is a commercial stage company.

    Comment?

  16. Critical Comparison: CuteraRead the original story w/Photo

    Jul 7, 2018 | AmericanBankingNews.com

    Cutera and BioSig Technologies are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and profitability. Cutera has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500.

    Comment?

  17. Research Analysts' Downgrades for July, 6th (AMSSY, CDNA, CEO,...Read the original story w/Photo

    Jul 6, 2018 | AmericanBankingNews.com

    According to Zacks, "CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients.

    Comment?

  18. Weekly Analysts' Ratings Updates for Aimmune TherapeuticsRead the original story w/Photo

    Jul 2, 2018 | AmericanBankingNews.com

    6/12/2018 - Aimmune Therapeutics was given a new $47.00 price target on by analysts at Credit Suisse Group AG. They now have a "buy" rating on the stock.

    Comment?

  19. OpGen (OPGN) versus CareDx (CDNA) Critical AnalysisRead the original story w/Photo

    Jul 2, 2018 | AmericanBankingNews.com

    CareDx and OpGen are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends. CareDx presently has a consensus price target of $12.13, indicating a potential downside of 0.94%.

    Comment?

  20. CareDx (CDNA) versus Fulgent Genetics (FLGT) Financial ContrastRead the original story w/Photo

    Jun 30, 2018 | AmericanBankingNews.com

    CareDx and Fulgent Genetics are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation. 52.6% of CareDx shares are owned by institutional investors.

    Comment?

Brisbane Job Listings
View or post Brisbane job listings on Topix.
Brisbane Real Estate
News, listings, and foreclosures in Brisbane from Topix.
Brisbane Mortgages
Find mortgage rates in Brisbane on Topix.